This story was originally published on Packaging Dive. To receive daily news and insights, subscribe to our free daily Packaging Dive newsletter. Packaging companies have offered up early gifts this holiday season in the form of announcements about planned investments in expansions and new jobs. Here are 10 recent commitments, many of which center on plastics production: American Packaging Corp. plans to invest nearly $8 million to build a 20,000-square-foot addition to its facility in Story City, Iowa. Th ...

Expedia Group, Inc. (EXPE) is a major travel technology company and one of the world’s largest online travel platforms. Headquartered in Seattle, Washington, it operates a broad portfolio of travel brands and digital services that enable consumers and partners to research, plan, book, and manage travel across flights, hotels, vacation rentals, car rentals, cruises, and activities With a market cap of $34.7 billion, the company is firmly positioned in the large-cap segment. It generates revenue from trans ...

Core Insights - The U.S. Department of Health and Human Services (HHS) has added Duchenne muscular dystrophy (DMD) to the recommended newborn screening panel, which is seen as a significant advancement in early diagnosis and potential treatment opportunities in the biotech sector [1] Group 1: Industry Impact - The addition of DMD to the newborn screening panel is expected to create new market opportunities for biotechnology companies focused on developing therapies for this condition [1] - This decision may lead to increased investment and research in the field of genetic disorders, particularly in the development of innovative treatments for DMD [1] Group 2: Analyst Perspective - The analyst emphasizes the importance of combining scientific expertise with financial analysis to identify promising biotechnology companies that are innovating in unique ways [1] - The focus is on evaluating the science behind drug candidates, the competitive landscape, clinical trial design, and potential market opportunities, while also considering financial fundamentals and valuation [1]

With a market cap of $75.4 billion, Cintas Corporation (CTAS) provides corporate identity uniforms and a broad range of related business services across the United States, Canada, and Latin America. The company operates through its Uniform Rental and Facility Services, First Aid and Safety Services, and other segments, serving customers through an extensive distribution network and local delivery routes. The Cincinnati, Ohio-based company is scheduled to announce its fiscal Q2 2026 results before the mar ...

There’s been no dearth of sell signals for Tesla Inc. It’s facing a potential sales halt in California, an electric vehicle slowdown across the US and is losing market share in China and Europe. But all that hasn’t deterred investors excited about its work with artificial intelligence and autonomous-driving development efforts. The carmaker’s shares have rallied 25% since a low on Nov. 21, notching a record for the first time this year. The stock has also outpaced the Bloomberg Magnificent Seven Index, wh ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV- 304) in patients with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin-based chemotherapy. The trial showed KEYTRUDA® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv), given as neoadjuvant and adjuvant treatment (before and after surgery), demonstrated a statistically signific. ...

Core Insights - Astellas Pharma and Pfizer announced positive topline results from the Phase 3 EV-304 clinical trial for PADCEV in combination with Keytruda, showing significant improvements in event-free survival and overall survival for muscle-invasive bladder cancer patients [1][5][7] Company Insights - Astellas Pharma is focused on advancing treatment options for muscle-invasive bladder cancer, with recent findings reinforcing the potential of PADCEV plus pembrolizumab to improve survival outcomes for a broad patient population [4][5] - Pfizer emphasizes the significance of the EV-304 results, indicating a potential shift in the standard of care for muscle-invasive bladder cancer patients, particularly those ineligible for platinum-based chemotherapy [5][6] Industry Insights - Muscle-invasive bladder cancer is a significant health concern, with nearly half of patients progressing to metastatic disease within three years of diagnosis, highlighting the need for effective treatment options [3][6] - The EV-304 trial results may lead to a new standard of care in bladder cancer treatment, moving away from conventional platinum-based chemotherapy [5][7]

Databricks has announced plans to raise more than $4bn in a Series L funding round that values the company at $134bn. The San Francisco-based data and AI company surpassed a $4.8bn revenue run-rate during its third quarter, with year-on-year growth of more than 55%. The run-rate figure includes more than $1bn from its data warehousing business and more than $1bn from its AI products. The company has delivered positive free cash flow over the 12 months since December 2024. Insight Partners, Fidelity Man ...

Oil Industry - U.S. crude futures increased by 2.4% to over $56 per barrel following President Trump's order for a blockade of sanctioned oil tankers off Venezuela [2][3] - The blockade represents a significant escalation in U.S.-Venezuela tensions, particularly after the recent seizure of a tanker off the Venezuelan coast [4] - Approximately 30% of Venezuela's oil shipments are at risk if U.S. sanctions continue to be enforced [5] - U.S. crude futures had previously dipped below $55 for the first time in nearly five years due to expectations of a potential easing of sanctions amid a possible Russia-Ukraine peace deal [6] - Analysts indicate that crude oil is nearing critical technical levels, with a potential downside break that could test the $50 mark [7] Consumer Finance - The CFO of Affirm Holdings (AFRM) reported that consumers currently feel healthy, with no signs of stress in repayment rates [8] - Approximately 96% of Affirm's transactions come from repeat borrowers, who typically exhibit lower default rates [9] - Delinquencies and repayment rates are aligning with expectations, indicating stable financial health for the company [10] - Affirm's shares rose nearly 12% after renewing a partnership with Amazon for an additional five years, reaching their highest point in a month [11] Rail Industry - The proposed $85 billion merger between Union Pacific (UNP) and Norfolk Southern (NSC) has lost support from two major unions representing over half of the workforce [12] - Concerns from the unions include increased safety risks, higher shipping rates, and potential disruptions to service [13] - The unions are set to announce their decision regarding the merger, which will be evaluated by the U.S. Surface Transportation Board for public interest [14]

Ford has canceled an electric vehicle battery contract with LG worth 9.6 trillion Korean won (US$6.52 billion). ...